Intensity Therapeutics (INTS) Return on Assets [ROA] (2023 - 2026)
Intensity Therapeutics (INTS) posted Return on Assets [ROA] of -93.78% for Q2 2026, up 246.23 percentage points from -340.01% a year earlier but down 11.58 percentage points from the prior quarter.
Powered by 
Analysis
Intensity Therapeutics (INTS) Return on Assets [ROA] (2023 - 2026) Analysis & Trends
For FY2025, Intensity Therapeutics' Return on Assets [ROA] came in at -124.89%, up 22.51 percentage points from FY2024.
- In prior years, Intensity Therapeutics' Return on Assets [ROA] was -147.40% in FY2024 (-60.27 pp) and -87.13% in FY2023.
- Quarterly Return on Assets [ROA] has run from a low of -383.46% in Q1 2025 to a high of -37.86% in Q3 2023 over five years.
- On a year-over-year basis, Return on Assets [ROA] has increased in each of the last four quarters, with an average year-over-year change of -17.23 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q1 2026, with a gain of 301.27 percentage points; the weakest was Q1 2025, with a drop of 305.59 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -82.19% (Q1 2026), -99.58% (Q4 2025) and -169.89% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.50 Bn | 1,103.09 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 500.82 Bn | 473.93 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 367.31 Bn | 321.69 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 297.77 Bn | 261.76 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 261.35 Bn | 235.04 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 235.40 Bn | 190.80 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 190.59 Bn | 164.79 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 169.39 Bn | 116.04 Bn | 10.94 Bn | 2.14% |
| 10 | Intensity Therapeutics | 8.85 Mn | -29.92 Mn | - | -93.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -93.78% |
| Mar 31, 2026 | -82.19% |
| Dec 31, 2025 | -99.58% |
| Sep 30, 2025 | -169.89% |
| Jun 30, 2025 | -340.01% |
| Mar 31, 2025 | -383.46% |
| Dec 31, 2024 | -325.55% |
| Sep 30, 2024 | -234.37% |
| Jun 30, 2024 | -143.19% |
| Mar 31, 2024 | -77.87% |
| Dec 31, 2023 | -48.66% |
| Sep 30, 2023 | -37.86% |
API Access
Intensity Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "INTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();